NDC 48102-047-11 - Dexamethasone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 48102-047
- Requested NDC
- 48102-047-11
- Package NDCs from labels
- 48102-047-01, 48102-047-11, 48102-047-20
- Manufacturer
- Fera Pharmaceuticals, LLC
- Effective date
- 2021-06-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexamethasone - Fera Pharmaceuticals, LLC | Fera Pharmaceuticals, LLC | 2021-06-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 48102-047-01 | EA - Each | 48102-047 | da6c292e-f7f5-4aa7-87fc-7f18f4a1c52a | 1 | 2018-07-03 |
| 48102-047-20 | EA - Each | 48102-047 | eaecba84-4502-4968-a4f6-3eaafe7480f6 | 1 | 2021-05-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dexamethasone | DEXAMETHASONE | Zydus Lifesciences Limited | 1e84a609-22a0-41b9-83a0-c45019c8cf9a | 2024-03-30 | 7S5I7G3JQL | |
| Dexamethasone | DEXAMETHASONE | Zydus Lifesciences Limited | 522a1a49-5540-4245-a15f-e3cdc0a97a5e | 2024-03-30 | 7S5I7G3JQL | |
| Dexamethasone | DEXAMETHASONE | Viona Pharmaceuticals Inc | 86afd383-7d6b-48f0-a803-9446fa1ded10 | 2024-03-29 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Chartwell RX, LLC | 3746066a-3c87-4238-945a-6dfb4d01a072 | 2024-03-14 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | NorthStar Rx LLC | 05c77a4c-c508-babd-e063-6294a90a450a | 2024-03-08 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | ANI Pharmaceuticals, Inc. | fe8cf911-84ef-47be-acb8-0501b546299b | 2024-03-04 | Warnings, Adverse reactions | 7S5I7G3JQL |
| dexamethasone | DEXAMETHASONE | Amneal Pharmaceuticals NY LLC | ac71f888-c83a-46a5-921c-1ebdf6cfadc1 | 2024-02-21 | Warnings, Adverse reactions | 7S5I7G3JQL |
| dexamethasone | DEXAMETHASONE | Amneal Pharmaceuticals NY LLC | b9eb9a30-c1da-4d38-8ea8-616a254e2afc | 2024-02-21 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Alvogen Inc. | 9ab26af9-8196-e3d3-76a3-75227fd4e1c3 | 2024-02-21 | Warnings, Adverse reactions | ANDA088481 7S5I7G3JQL |
| Neo/Poly-B/Dex Ophth Oint | NEO/POLY-B/DEX OPHTH OINT | Direct_Rx | 0ec1dfdf-b63f-fb0c-e063-6294a90a843d | 2024-01-12 | Warnings, Adverse reactions | 7S5I7G3JQL |
| TOBRAMYCIN AND DEXAMETHASONE | TOBRAMYCIN AND DEXAMETHASONE | Bryant Ranch Prepack | a5f0b05b-3dec-4fe8-8106-e41e668a512d | 2024-01-12 | Warnings, Adverse reactions | 7S5I7G3JQL |
| TOBRAMYCIN AND DEXAMETHASONE | TOBRAMYCIN AND DEXAMETHASONE | Bryant Ranch Prepack | 3c63c481-ce57-41ca-993f-5a5b665fa1e4 | 2024-01-12 | Warnings, Adverse reactions | 7S5I7G3JQL |
| DEXAMETHASONE | DEXAMETHASONE | Direct Rx | 3ff06262-4c6f-4423-99fa-b4d8191ea133 | 2024-01-09 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone 1.5 mg | DEXAMETHASONE 1.5 MG | Proficient Rx LP | 42db0356-3948-444c-bda3-1226b4ca8985 | 2024-01-01 | Warnings, Adverse reactions | 7S5I7G3JQL |
| MAXITROL | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Sandoz Inc | 5776c435-ac60-49b6-8db1-23a3012b9155 | 2023-12-29 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Ciprofloxacin and dexamethasone | CIPROFLOXACIN AND DEXAMETHASONE | ARMAS PHARMACEUTICALS INC. | eed6b293-6bbe-4bd3-ad9d-3849e0eb6c05 | 2023-11-17 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE | A-S Medication Solutions | 0d273133-0ce9-4fe6-b873-7f85aac25486 | 2023-11-01 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | H3R47K3TBD |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | I753WB2F1M |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | I753WB2F1M |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.